Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y. Baron F, et al. Among authors: beguin y. J Hematol Oncol. 2015 Feb 6;8:4. doi: 10.1186/s13045-014-0098-9. J Hematol Oncol. 2015. PMID: 25652604 Free PMC article. Clinical Trial.
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Castermans E, Hannon M, Dutrieux J, Humblet-Baron S, Seidel L, Cheynier R, Willems E, Gothot A, Vanbellinghen JF, Geenen V, Sandmaier BM, Storb R, Beguin Y, Baron F. Castermans E, et al. Among authors: beguin y. Haematologica. 2011 Feb;96(2):298-306. doi: 10.3324/haematol.2010.029702. Epub 2010 Oct 7. Haematologica. 2011. PMID: 20934996 Free PMC article.
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
Beguin Y, Maertens J, De Prijck B, Schots R, Seidel L, Bonnet C, Hafraoui K, Willems E, Vanstraelen G, Servais S, Jaspers A, Fillet G, Baron F. Beguin Y, et al. Am J Hematol. 2013 Dec;88(12):990-6. doi: 10.1002/ajh.23552. Epub 2013 Sep 30. Am J Hematol. 2013. PMID: 23873823 Free article. Clinical Trial.
Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning.
Hannon M, Beguin Y, Ehx G, Servais S, Seidel L, Graux C, Maertens J, Kerre T, Daulne C, de Bock M, Fillet M, Ory A, Willems E, Gothot A, Humblet-Baron S, Baron F. Hannon M, et al. Among authors: beguin y. Clin Cancer Res. 2015 Jul 15;21(14):3131-9. doi: 10.1158/1078-0432.CCR-14-3374. Epub 2015 Mar 16. Clin Cancer Res. 2015. PMID: 25779951 Free article. Clinical Trial.
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
Canti L, Humblet-Baron S, Desombere I, Neumann J, Pannus P, Heyndrickx L, Henry A, Servais S, Willems E, Ehx G, Goriely S, Seidel L, Michiels J, Willems B, Liston A, Ariën KK, Beguin Y, Goossens ME, Marchant A, Baron F. Canti L, et al. Among authors: beguin y. J Hematol Oncol. 2021 Oct 24;14(1):174. doi: 10.1186/s13045-021-01190-3. J Hematol Oncol. 2021. PMID: 34689821 Free PMC article.
441 results